Several conditions may benefit from TMS therapy. However, only three have been approved by the Food and Drug Administration (FDA): depression, OCD, and nicotine addiction. The FDA indicates that ...
Biohaven initiated a pivotal Phase 2 trial evaluating BHV-2100 in the acute treatment of migraineBHV-2100 is a potential first-in-class, potent, orally administered Transient Receptor Potential ...
There are 70 million autistic in the world, QPAN® Model offers personalise real-time brain data and an AI-driven system to make it truly bespoke. Damien Hayward Coso Agency email us here Visit us on ...
Patrick McGrath, PhD, is lead psychologist at Ascension Illinois Alexian Brothers Behavioral Health Hospital and chief clinical officer at NOCD, an online treatment option for people with OCD. Olivia ...